We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Drug firm Cadila Healthcare announced that it has received establishment inspection report from the US health regulator with voluntary action indicated (VAI) classification for its Ahmedabad SEZ facility.